I graduated from Columbia College of Physicians & Surgeons, where I stayed for Internal Medicine residency training/chief residency before moving to Boston for fellowship training in hematology/oncology at Dana-Farber/Mass General Cancer Center. I stayed on as faculty in the lymphoma program at Dana-Farber and am now an Assistant Professor of Medicine at Harvard Medical School.  My research interests are in the clinical and translational study of immunotherapies for lymphoma, with a particular interest in cellular immunotherapies. I also serve as the Medical Director of the Immune Effector Cell Therapy program at Dana-Farber, which houses our commercial and research cell therapy programs across the Institute.  I am the principal investigator of industry-sponsored and investigator-initiated clinical trials involving cellular therapies for lymphoma, and lead retrospective and translational studies to identify mechanisms of response and resistance to these therapies.